Class action suit targets Novartis

Share this article:
A US judge has ruled that Novartis Pharmaceuticals will have to defend itself against sex-discrimination claims brought by a group of female sales reps in a $100 million class-action lawsuit.

Judge Gerald Lynch granted class-action status to a lawsuit in US District Court in Manhattan against Novartis by 19 current and former sales employees.

The lawsuit, filed in 2004, alleged Novartis' pharma unit was discriminatory in its pay, promotions, evaluations and treatment of women who take pregnancy leave. About 5,000 women are believed to qualify as plaintiffs.

A Novartis spokesman said in published reports at press time that lawyers were still reviewing related documents.  

Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.